Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-02-25 @ 11:06 PM
Study NCT ID:
NCT06427668
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-17
First Post:
2024-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD)
Sponsor:
Spinogenix
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPG302-ALZ-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None